These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 1931935

  • 21. Compulsive personality as predictor of response to serotoninergic antidepressants.
    Ansseau M, Troisfontaines B, Papart P, von Frenckell R.
    BMJ; 1991 Sep 28; 303(6805):760-1. PubMed ID: 1932937
    [No Abstract] [Full Text] [Related]

  • 22. Fluvoxamine pharmacotherapy of anxiety disorders in later life: preliminary open-trial data.
    Wylie ME, Miller MD, Shear MK, Little JT, Mulsant BH, Pollock BG, Reynolds CF.
    J Geriatr Psychiatry Neurol; 2000 Sep 28; 13(1):43-8. PubMed ID: 10753007
    [Abstract] [Full Text] [Related]

  • 23. The antidepressant effects of 5-HT uptake inhibitors.
    Aberg-Wistedt A.
    Br J Psychiatry Suppl; 1989 Dec 28; (8):32-40. PubMed ID: 2692638
    [Abstract] [Full Text] [Related]

  • 24. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety.
    Murphy DL, Pigott TA.
    J Clin Psychiatry; 1990 Apr 28; 51 Suppl():53-8; discussion 59-60. PubMed ID: 2139026
    [Abstract] [Full Text] [Related]

  • 25. The selective effects of serotonin reuptake inhibitors.
    Montgomery SA.
    Clin Neuropharmacol; 1992 Apr 28; 15 Suppl 1 Pt A():353A-354A. PubMed ID: 1498869
    [No Abstract] [Full Text] [Related]

  • 26. [Antidepressive agents in non-depressive disorders].
    Peyré F.
    Rev Prat; 1994 Nov 01; 44(17):2299-301. PubMed ID: 7984935
    [Abstract] [Full Text] [Related]

  • 27. [A serotoninergic antidepressive, indalpine].
    Rigal J.
    Ann Med Psychol (Paris); 1985 Jul 01; 143(7):664-76. PubMed ID: 3938629
    [No Abstract] [Full Text] [Related]

  • 28. Recent studies on selective serotonergic antidepressants: trazodone, fluoxetine, and fluvoxamine.
    Schatzberg AF, Dessain E, O'Neil P, Katz DL, Cole JO.
    J Clin Psychopharmacol; 1987 Dec 01; 7(6 Suppl):44S-49S. PubMed ID: 3123528
    [Abstract] [Full Text] [Related]

  • 29. Obsessive-compulsive disorder.
    Zetin M, Kramer MA.
    Hosp Community Psychiatry; 1992 Jul 01; 43(7):689-99. PubMed ID: 1516899
    [Abstract] [Full Text] [Related]

  • 30. Therapeutic applications and mechanisms of action of monoamine oxidase inhibitor and heterocyclic antidepressant drugs.
    Goodman WK, Charney DS.
    J Clin Psychiatry; 1985 Oct 01; 46(10 Pt 2):6-24. PubMed ID: 3900056
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Serotonin syndrome-like symptoms in a patient with obsessive-compulsive disorder, following inappropriate increase in fluvoxamine dosage.
    Lenzi A, Raffaelli S, Marazziti D.
    Pharmacopsychiatry; 1993 May 01; 26(3):100-1. PubMed ID: 8415895
    [No Abstract] [Full Text] [Related]

  • 33. Epidemiological data of patients treated with fluvoxamine: results from a 12 week non-comparative multicentre study.
    Dewulf L, Hendrickx B, Lesaffre E.
    Int Clin Psychopharmacol; 1995 Jan 01; 9 Suppl 4():67-72. PubMed ID: 7622826
    [Abstract] [Full Text] [Related]

  • 34. Treatment of obsessive compulsive disorder: psychotherapies, drugs, and other somatic treatment.
    Greist JH.
    J Clin Psychiatry; 1990 Aug 01; 51 Suppl():44-50; discussion 55-8. PubMed ID: 2116405
    [Abstract] [Full Text] [Related]

  • 35. The potential role of serotonin reuptake inhibitors in the treatment of obsessive compulsive disorder.
    Zak JP, Miller JA, Sheehan DV, Fanous BS.
    J Clin Psychiatry; 1988 Aug 01; 49 Suppl():23-9. PubMed ID: 3045108
    [Abstract] [Full Text] [Related]

  • 36. Serotonergic probes in obsessive compulsive disorder.
    Zohar J, Kindler S.
    Int Clin Psychopharmacol; 1992 Jun 01; 7 Suppl 1():39-40. PubMed ID: 1517556
    [No Abstract] [Full Text] [Related]

  • 37. Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder.
    McDougle CJ, Goodman WK, Leckman JF, Holzer JC, Barr LC, McCance-Katz E, Heninger GR, Price LH.
    Am J Psychiatry; 1993 Apr 01; 150(4):647-9. PubMed ID: 8465885
    [Abstract] [Full Text] [Related]

  • 38. Serotonin and treatment in obsessive-compulsive disorder.
    March JS, Gutzman LD, Jefferson JW, Greist JH.
    Psychiatr Dev; 1989 Apr 01; 7(1):1-18. PubMed ID: 2508084
    [Abstract] [Full Text] [Related]

  • 39. Management of comorbid anxiety and depression.
    Zajecka JM, Ross JS.
    J Clin Psychiatry; 1995 Apr 01; 56 Suppl 2():10-3. PubMed ID: 7844101
    [Abstract] [Full Text] [Related]

  • 40. Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder.
    McDougle CJ, Goodman WK, Price LH, Delgado PL, Krystal JH, Charney DS, Heninger GR.
    Am J Psychiatry; 1990 May 01; 147(5):652-4. PubMed ID: 1970224
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.